期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 491, 期 1, 页码 9-19出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2004.03.026
关键词
adenosine; dipyridamole; draflazine; nitrobenzylthioinosine; transporter
We studied the binding of [H-3]nitrobenzylthioinosine (NBMPR) and the uptake [H-3]formycin B by the es (equilibrative inhibitor-sensitive) nucleoside transporter of Madin Darby Canine Kidney (MDCK) cells. NBMPR inhibited [H-3]formycin B uptake with a K-i of 2.7 +/- 0.6 nM, and [H-3]NBMPR had a K-D of 1.3 +/- 0.3 nM for binding to these cells; these values are significantly higher than those obtained in human and mouse cell models. In contrast, other recognized es inhibitors, such as dipyridamole, were significantly more effective as inhibitors of [H-3]NBMPR binding and [H-3]formycin B uptake by MDCK cells relative to that seen for human cells. We isolated a cDNA encoding the canine es nucleoside transporter (designated cENTI), and assessed its function by stable expression in nucleoside transport deficient PK15NTD cells. The PK15-cENTI cells displayed inhibitor sensitivities that were comparable to those obtained for the endogenous es nucleoside transporter in MDCK cells. These data indicate that the dog es/ENTI transporter has distinctive inhibitor binding characteristics, and that these characteristics are a function of the protein structure as opposed to the environment in which it is expressed. (C) 2004 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据